Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CGRP
Biotech
Biohaven pain spray aces test amid C-suite shake-up
Biohaven is eyeing filing for approval early next year for its experimental pain spray after data showed it hit its primary endpoints in a phase 3.
Ben Adams
Dec 6, 2021 10:00am
Alder builds case for CGRP migraine drug eptinezumab
Apr 26, 2018 5:36am
Biohaven slumps on oral migraine drug data
Mar 26, 2018 8:46am
Biohaven pushes the gas on oral migraine drug
Nov 27, 2017 8:45am
